Kolexia
Buisson Anthony Gastro-entérologie
Buisson Anthony
Gastro-entérologie
Hôpital Estaing
Clermont-Ferrand, France
314 Activités
466 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Nécrose Inflammation Ulcère Infections à Escherichia coli Complications postopératoires

Collaborateurs

Voir plus
Nancey Stephane
Nancey Stephane
Hôpital Lyon Sud, Pierre-Bénite, France
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Fumery Mathurin
Fumery Mathurin
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France

Industries

Voir plus
Janssen
69 collaboration(s)
Dernière en 2023
Abbvie
51 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
16 collaboration(s)
Dernière en 2023
Pfizer
14 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
RECIDREAM: Evaluation of Sleep Changes as Early Markers of Relapse in Patients With Inflammatory Bowel Diseases (IBD).
Essai Clinique (Hospices Civils de Lyon)   18 mars 2024
Étude APPETISER : avantage au traitement le plus efficace d’emblée dans la RCH
Edimark   24 février 2024
Physical Activity and IBD: State of Art and Knowledge, Patients and Healthcare Professionals Points of View, A French Multicenter Cross Sectional Study.
Inflammatory bowel diseases   08 février 2024
TOPIC: TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study
Essai Clinique (Hospices Civils de Lyon)   29 janvier 2024
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   27 janvier 2024
USTAP: USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
Essai Clinique (Janssen)   18 janvier 2024
TRENCH 1: TRansmural hEaliNg Definition in CroHn's Disease - The TRENCH1 Study
Essai Clinique (Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives)   15 janvier 2024
Prevalence of FGF23 elevation in patients with hypophosphatemia.
Clinica chimica acta; international journal of clinical chemistry   13 janvier 2024
ABTECT - Maintenance: A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023